Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Enterprise Value (2021 - 2026)

Invivyd's (IVVD) quarterly Enterprise Value came in at $96.4 million in Q2 2026, up 91.2% on a YoY basis from $50.4 million in Q2 2025, and down 51.5% quarter-over-quarter from $198.7 million in Q4 2025.

Analysis

Invivyd (IVVD) Enterprise Value (2021 - 2026) Analysis & Trends

Invivyd (IVVD) has reported Enterprise Value for 6 consecutive years, with $96.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Enterprise Value rose 91.2% year-over-year to $96.4 million; the trailing twelve-month figure through Jun 2026 stood at $96.4 million (up 91.2% YoY), and the FY2025 full-year result was $198.7 million, up 1295.3% from the prior year.
  • Enterprise Value slipped to $96.4 million in Q2 2026 per IVVD's latest filing, from $198.7 million in the prior quarter.
  • Across five years, Enterprise Value topped out at $340.0 million in Q1 2024 and bottomed at -$118.1 million in Q2 2022.
  • Historically, Enterprise Value has averaged $59.7 million across 5 years, with a median of $25.1 million in 2025.
  • The widest YoY moves for Enterprise Value: up 7123.12% in 2024, down 139.11% in 2024.
  • Over 5 years, Enterprise Value stood at $71.5 million in 2022, then surged by 226.47% to $233.4 million in 2023, then sank by 107.12% to -$16.6 million in 2024, then soared by 1295.3% to $198.7 million in 2025, then slumped by 51.5% to $96.4 million in 2026.
  • According to Business Quant data, Enterprise Value over the past three periods registered $96.4 million, $198.7 million, and $102.2 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 96.36 Mn
Dec 31, 2025 198.68 Mn
Sep 30, 2025 102.22 Mn
Jun 30, 2025 50.40 Mn
Mar 31, 2025 25.10 Mn
Dec 31, 2024 -16.62 Mn
Sep 30, 2024 15.13 Mn
Jun 30, 2024 -16.49 Mn
Mar 31, 2024 339.95 Mn
Dec 31, 2023 233.39 Mn
Sep 30, 2023 4.92 Mn
Jun 30, 2023 -6.90 Mn
Mar 31, 2023 4.71 Mn
Dec 31, 2022 71.49 Mn
Sep 30, 2022 62.88 Mn
Jun 30, 2022 -118.08 Mn
Mar 31, 2022 -32.10 Mn
Dec 31, 2021 -232.79 Mn
Sep 30, 2021 2.11 Bn